Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis. Drellia K, Kokoti L, Deligianni CI, Papadopoulos D, et al. Cephalalgia 2021 Feb 10:333102421989601. doi: 10.1177/0333102421989601.

Read + Share

Amedeo Smart

Independent Medical Education

Drellia K, Kokoti L, Deligianni CI, Papadopoulos D, et al. Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis. Cephalalgia 2021 Feb 10:333102421989601. doi: 10.1177/0333102421989601.
PMID: 33567891